Latest market price
23.86
-0.75-3.05%
TA
Loading chart...
Snapshot
| Index | — | P/E | — | EPS (ttm) | 0.07 | Insider Own | 27.59% | Shs Outstand | 123.61M | Perf Week | -5.62% |
| Market Cap | 2.95B | Forward P/E | 38.47 | EPS next Y | 0.62 | Insider Trans | -2.35% | Shs Float | 94.62M | Perf Month | -11.73% |
| Enterprise Value | 2.91B | PEG | 9.80 | EPS next Q | 0.09 | Short Float | 21.67% | Perf Quarter | -20.25% | ||
| Income | 8.00M | P/S | 3.23 | EPS this Y | 13.87% | Short Ratio | 7.09 | Perf Half Y | 8.50% | ||
| Sales | 912.00M | P/B | 7.52 | EPS next Y | 47.81% | ROA | 1.00% | Short Interest | 20.50M | Perf YTD | 9.50% |
| Book/sh | 3.17 | P/C | 10.07 | EPS next 5Y | 34.78% | ROE | 2.06% | 52W High | 31.00 -23.03% | Perf Year | 23.82% |
| Cash/sh | 2.37 | P/FCF | 140.44 | EPS past 3/5Y | — | ROIC | 0.19% | 52W Low | 14.96 59.49% | Perf 3Y | 79.80% |
| Dividend Est. | — | EV/EBITDA | 46.15 | Sales past 3/5Y | 13.40% 17.22% | Gross Margin | 54.68% | Volatility | 5.25% 5.17% | Perf 5Y | -59.58% |
| Dividend TTM | — | EV/Sales | 3.19 | EPS Y/Y TTM | — | Oper. Margin | 0.17% | ATR (14) | 1.41 | Perf 10Y | — |
| Dividend Ex-Date | — | Quick Ratio | 2.01 | Sales Y/Y TTM | 11.08% | Profit Margin | 0.85% | RSI (14) | 41.78 | Recom | 2.44 |
| Dividend Gr. 3/5Y | — | Current Ratio | 2.27 | EPS Q/Q | 62.50% | SMA20 | -5.09% | Beta | 1.92 | Target Price | 30.33 |
| Payout | 0.00% | Debt/Eq | 0.64 | Sales Q/Q | 10.28% | SMA50 | -4.81% | Rel Volume | 1.29 | Prev Close | 24.61 |
| Employees | 4,036 | LT Debt/Eq | 0.55 | Earnings | Nov 05 | SMA200 | -5.09% | Avg Volume | 2.93M | Price | 23.86 |
| IPO Date | Sep 29, 2021 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 27.84% -1.04% | Net Debt/EBITDA | -0.67 | Volume | 3,771,383 | Change | -3.05% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Sep-17-26 | Reiterated | Deutsche Bank | $29 | |
| Aug-07-26 | Reiterated | UBS | Neutral | $27 → $28 |
| Aug-05-26 | Reiterated | Roth Capital | Neutral | $24 → $28 |
| May-22-26 | Reiterated | China Renaissance Securities (US) Inc. | $30 | |
| May-08-26 | Reiterated | Telsey Advisory | Outperform | $32 → $33 |
| May-08-26 | Reiterated | UBS | Neutral | $20 → $27 |
| May-07-26 | Reiterated | BTIG | Buy | $32 → $34 |
| Feb-25-26 | Reiterated | UBS | Neutral | $23 → $20 |
| Dec-17-25 | Reiterated | Telsey Advisory | Outperform | $24 → $32 |
| Dec-17-25 | Reiterated | Robert W. Baird | $27 → $35 |
Latest News· Times ET
Oct-20-26
Oct-18-26
Oct-18-2602:15AM
Oct-15-26
04:05PM
Oct-05-26
Oct-04-26
Oct-04-2608:02AM
Sep-30-26
Sep-30-2604:45PM
06:21AM
Sep-29-26
Sep-29-2602:38PM
Sep-28-26
Sep-25-26
Sep-25-2610:43AM
Sep-24-26
Sep-24-2604:28PM
Sep-21-26
Sep-18-26
Sep-18-2607:43PM
Company
Warby Parker Inc. operates as a purveyor of optical products and related services. Their extensive product line includes prescription eyeglasses, sunglasses, and contact lenses, alongside specialized lens options such as light-responsive (photochromic) and blue-light-filtering variants. Customers can also acquire a variety of accessories, including protective cases, lens care kits equipped with anti-fog spray, pouches, and individual anti-fog lens sprays. Beyond product sales, Warby Parker facilitates direct-to-consumer eye examinations and vision assessments. These services are accessible through their physical retail locations, online platform, and dedicated mobile applications. By May 16, 2022, the company had established a network of 160 brick-and-mortar stores across the United States and Canada. Originally incorporated as JAND, Inc. in 2009, the organization officially rebranded to Warby Parker Inc. in June 2021. Its corporate headquarters are situated in New York, New York.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 912 | 872 | 771 | 670 | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 413 | 401 | 344 | 305 | — | — | — | — | |
| Gross Profit | 498 | 471 | 427 | 365 | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 363 | 476 | 440 | 422 | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | |
| Other Operating Expense | 133 | 0 | 17 | 15 | — | — | — | — | |
| Operating Income | 2 | -5 | -30 | -72 | — | — | — | — | |
| Interest Expense | 0 | 0 | 0 | 0 | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 8 | 8 | 11 | 9 | — | — | — | — | |
| Net Income Before Taxes | 10 | 3 | -20 | -63 | — | — | — | — | |
| Income Taxes | 3 | 1 | 1 | 0 | — | — | — | — | |
| Consolidated Net Income | 8 | 2 | -20 | -63 | — | — | — | — | |
| Net Income From Continuing Operations | 8 | 2 | -20 | -63 | — | — | — | — | |
| Net Income | 8 | 2 | -20 | -63 | — | — | — | — | |
| EPS (Recurring) | 0.07 | 0.01 | -0.17 | -0.54 | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 0.07 | 0.01 | -0.17 | -0.54 | — | — | — | — | |
| EPS (Diluted) | 0.07 | 0.01 | -0.17 | -0.54 | — | — | — | — | |
| EBITDA | 63 | 53 | 26 | -24 | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 340.86 | 1,663.36 | — | — | — | — | — | — | |
| Price To Sales Ratio | 3.24 | 3.07 | 3.77 | 2.46 | — | — | — | — | |
| Gross Margin | 54.61 | 54.01 | 55.38 | 54.48 | — | — | — | — | |
| Operating Margin | 0.22 | -0.57 | -3.89 | -10.75 | — | — | — | — | |
| Net Margin | 0.88 | 0.23 | -2.59 | -9.40 | — | — | — | — | |
| Shares Outstanding | 124 | 123 | 120 | 117 | — | — | — | — | |
| Market Capitalization | 2,959 | 2,680 | 2,905 | 1,650 | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Raider Jeffrey Jacob | Director | Oct 01 '26 | Sale | 27.70 | 15,000 | 415,500 | 420,201 | Oct 02 |
| Blumenthal Neil Harris | Co-Chief Executive Officer | Oct 01 '26 | Sale | 27.69 | 100,000 | 2,769,000 | 36,020 | Oct 02 |
| Gilboa David Abraham | Co-Chief Executive Officer | Sep 02 '26 | Option Exercise | 0.00 | 65,438 | 0 | 4,600,044 | Sep 04 |
| Blumenthal Neil Harris | Co-Chief Executive Officer | Sep 02 '26 | Option Exercise | 0.00 | 65,438 | 0 | 3,465,090 | Sep 04 |
| Blumenthal Neil Harris | Co-Chief Executive Officer | Aug 12 '26 | Option Exercise | 0.00 | 200,000 | 0 | 3,420,450 | Aug 14 |
| Blumenthal Neil Harris | Co-Chief Executive Officer | Jul 06 '26 | Sale | 29.99 | 9,200 | 275,908 | 31,112 | Jul 08 |
| Gilboa David Abraham | Co-Chief Executive Officer | Jul 06 '26 | Option Exercise | 0.00 | 54,347 | 0 | 4,609,751 | Jul 08 |
| Gilboa David Abraham | Co-Chief Executive Officer | Jul 06 '26 | Sale | 29.84 | 54,347 | 1,621,714 | 31,112 | Jul 08 |
| Blumenthal Neil Harris | Co-Chief Executive Officer | Jul 01 '26 | Sale | 29.61 | 217,667 | 6,445,120 | 31,112 | Jul 02 |
| Gilboa David Abraham | Co-Chief Executive Officer | Jul 01 '26 | Option Exercise | 0.00 | 117,221 | 0 | 4,769,150 | Jul 02 |
| Gilboa David Abraham | Co-Chief Executive Officer | Jul 01 '26 | Sale | 29.69 | 242,221 | 7,191,541 | 31,112 | Jul 02 |
| Raider Jeffrey Jacob | Director | Jul 01 '26 | Sale | 29.72 | 22,500 | 668,700 | 435,201 | Jul 02 |
| Blumenthal Neil Harris | Co-Chief Executive Officer | Jun 29 '26 | Option Exercise | 0.00 | 36,300 | 0 | 95,759 | Jul 01 |
| Blumenthal Neil Harris | Co-Chief Executive Officer | Jun 29 '26 | Sale | 30.04 | 36,300 | 1,090,452 | 59,459 | Jul 01 |
| Blumenthal Neil Harris | Co-Chief Executive Officer | Jun 18 '26 | Option Exercise | 0.00 | 200,000 | 0 | 3,177,577 | Jun 23 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.